These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15090249)

  • 21. Kinetics studies on the inhibition mechanism of pancreatic α-amylase by glycoconjugated 1H-1,2,3-triazoles: a new class of inhibitors with hypoglycemiant activity.
    Senger MR; Gomes Lda C; Ferreira SB; Kaiser CR; Ferreira VF; Silva FP
    Chembiochem; 2012 Jul; 13(11):1584-93. PubMed ID: 22753086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-linear, non-competitive inhibition of lactate dehydrogenase with carboxylic acid anions (substrate analogues)].
    Saburova EA; Gol'dshteĭn BN; Elfimova LI; Vol'kenshteĭn MV
    Mol Biol (Mosk); 1982; 16(6):1173-82. PubMed ID: 7155138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical steady-state enzyme kinetics.
    Lorsch JR
    Methods Enzymol; 2014; 536():3-15. PubMed ID: 24423262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new plot for multiple enzyme inhibition.
    Palatini P
    Biochem Int; 1983 Aug; 7(2):247-53. PubMed ID: 6383391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Src tyrosine kinase substrate binding site inhibitors.
    Ye G; Tiwari R; Parang K
    Curr Opin Investig Drugs; 2008 Jun; 9(6):605-13. PubMed ID: 18516760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic analysis of the L-ornithine transcarbamoylase from Pseudomonas savastanoi pv. phaseolicola that is resistant to the transition state analogue (R)-N delta-(N'-sulfodiaminophosphinyl)-L-ornithine.
    Templeton MD; Reinhardt LA; Collyer CA; Mitchell RE; Cleland WW
    Biochemistry; 2005 Mar; 44(11):4408-15. PubMed ID: 15766270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the baculovirus anti-apoptotic protein p35 with caspases. Specificity, kinetics, and characterization of the caspase/p35 complex.
    Zhou Q; Krebs JF; Snipas SJ; Price A; Alnemri ES; Tomaselli KJ; Salvesen GS
    Biochemistry; 1998 Jul; 37(30):10757-65. PubMed ID: 9692966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic properties of pyruvate kinase in human maternal leukocytes in fetal malnutrition.
    Mameesh MS; Metcoff J; Costiloe P; Crosby W
    Pediatr Res; 1976 Jun; 10(6):561-5. PubMed ID: 1272633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Domain closure, substrate specificity and catalysis of D-lactate dehydrogenase from Lactobacillus bulgaricus.
    Razeto A; Kochhar S; Hottinger H; Dauter M; Wilson KS; Lamzin VS
    J Mol Biol; 2002 Apr; 318(1):109-19. PubMed ID: 12054772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of slow-binding enzyme inhibitors at elevated enzyme concentrations.
    Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E
    Anal Biochem; 2005 Feb; 337(2):211-23. PubMed ID: 15691501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular interpretation of inhibition by excess substrate in flavocytochrome b2: a study with wild-type and Y143F mutant enzymes.
    Rouvière N; Mayer M; Tegoni M; Capeillère-Blandin C; Lederer F
    Biochemistry; 1997 Jun; 36(23):7126-35. PubMed ID: 9188712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of activating cations and inhibitor on the allosteric regulation of rabbit muscle pyruvate kinase.
    Li F; Yu T; Jiang H; Yu S
    Int J Biol Macromol; 2013 Sep; 60():219-25. PubMed ID: 23748005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of bromosulphophthalein binding to human glutathione S-transferase A1-1: thermodynamics and inhibition kinetics.
    Kolobe D; Sayed Y; Dirr HW
    Biochem J; 2004 Sep; 382(Pt 2):703-9. PubMed ID: 15147239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjugated polyelectrolyte based real-time fluorescence assay for adenylate kinase.
    Liu Y; Schanze KS
    Anal Chem; 2009 Jan; 81(1):231-9. PubMed ID: 19117453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic and kinetic studies of inhibition of enzymes.
    Whiteley CG
    Cell Biochem Biophys; 2000; 33(3):217-25. PubMed ID: 11325042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calculation of inhibitor Ki and inhibitor type from the concentration of inhibitor for 50% inhibition for Michaelis-Menten enzymes.
    Brandt RB; Laux JE; Yates SW
    Biochem Med Metab Biol; 1987 Jun; 37(3):344-9. PubMed ID: 3606895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.
    Chou TC; Talalay P
    Adv Enzyme Regul; 1984; 22():27-55. PubMed ID: 6382953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Half-time analysis of the kinetics of irreversible enzyme inhibition by an unstable site-specific reagent.
    Topham CM
    Biochim Biophys Acta; 1988 Jun; 955(1):65-76. PubMed ID: 3382673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of inhibition constants, I50 values and the type of inhibition for enzyme-catalyzed reactions.
    Duggleby RG
    Biochem Med Metab Biol; 1988 Oct; 40(2):204-12. PubMed ID: 3190925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of substrate reaction during irreversible modification of enzyme activity for enzymes involving two substrates.
    Wang ZX; Tsou CL
    J Theor Biol; 1987 Aug; 127(3):253-70. PubMed ID: 3431125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.